ArticleAsian journal of neurosurgery2026
Cerebrospinal Fluid and Blood Lactate and Procalcitonin for Diagnosis of Post-neurosurgical Bacterial Meningitis.
Article in Asian journal of neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To investigate the diagnostic value of lactate and procalcitonin levels in cerebrospinal fluid (CSF) and blood for the diagnosis of post-neurosurgical bacterial meningitis (PNBM). Materials and Methods: A 2-year prospective study was conducted at the Faculty of Medicine, Vajira Hospital, Bangkok, Thailand. Data were collected on patient demographics, underlying disease, time to suspected PNBM, operative time, preoperative antibiotic use, blood lactate and procalcitonin levels, and CSF cell count, cell differentiation, protein, glucose, lactate, and procalcitonin levels. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were calculated using Fisher's exact test. Results: A CSF lactate level greater than 4 mmol/L showed a sensitivity of 82.2%, specificity of 62.5%, positive predictive value of 92.5%, negative predictive value of 38.5%, and accuracy of 39.62%. A CSF procalcitonin level greater than 0.075 ng/mL showed a sensitivity of 100%, specificity of 0%, positive predictive value of 100%, negative predictive value of 0%, and accuracy of 100%. A blood lactate level greater than 2 mmol/L showed a sensitivity of 17.8%, specificity of 100%, positive predictive value of 100%, negative predictive value of 17.8%, and accuracy of 43.24%. A blood procalcitonin level greater than 0.25 ng/mL showed a sensitivity of 40%, specificity of 50%, positive predictive value of 81.8%, negative predictive value of 12.9%, and accuracy of 44.23%. CSF lactate >5.25 mmol/L had a specificity of 100%, and CSF/blood lactate ratio >7.07 had a specificity of 100% for PNBM diagnosis. Conclusion: CSF lactate and the CSF/blood lactate ratio are useful in the diagnosis of PNBM. However, CSF procalcitonin, blood lactate, blood procalcitonin, and the CSF/blood procalcitonin ratio are not reliable for diagnosing PNBM. CSF lactate greater than 5.25 mmol/L and CSF/blood lactate ratio greater than 7.07 are highly specific for the diagnosis of PNBM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.